Shield Therapeutics plc
SHIEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $7 | $8 | – |
| Short-Term Investments | $0 | $0 | $0 | – |
| Receivables | $24 | $23 | $12 | – |
| Inventory | $7 | $6 | $3 | – |
| Other Curr. Assets | $0 | $1 | $0 | – |
| Total Curr. Assets | $41 | $38 | $22 | – |
| Property Plant & Equip (Net) | $0 | $0 | $1 | – |
| Goodwill | $0 | $0 | $0 | – |
| Intangibles | $20 | $18 | $17 | – |
| Long-Term Investments | $0 | $0 | $1 | – |
| Tax Assets | $0 | $0 | $0 | – |
| Other NC Assets | $1 | $1 | -$4 | – |
| Total NC Assets | $21 | $20 | $15 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $62 | $57 | $37 | – |
| Liabilities | – | – | – | – |
| Payables | $16 | $7 | $15 | – |
| Short-Term Debt | $0 | $0 | $0 | – |
| Tax Payable | $0 | $0 | $4 | – |
| Deferred Revenue | $0 | $0 | $0 | – |
| Other Curr. Liab. | $34 | $17 | $5 | – |
| Total Curr. Liab. | $50 | $33 | $21 | – |
| LT Debt | $27 | $26 | $16 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $0 | $0 | $0 | – |
| Other NC Liab. | $0 | $0 | $0 | – |
| Total NC Liab. | $27 | $26 | $16 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $0 | $0 | $0 | – |
| Total Liabilities | $77 | $59 | $37 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | – |
| Common Stock | $20 | $20 | $12 | – |
| Retained Earnings | -$269 | -$260 | -$197 | – |
| AOCI | $0 | $0 | $28 | – |
| Other Equity | $31 | $35 | $0 | – |
| Total Equity | -$15 | -$1 | $0 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | – |
| Total Liab. & Tot. Equity | $62 | $57 | $37 | – |
| Net Debt | $16 | $20 | $7 | $0 |